KRAS and lung carcinoma: To investigate the regulatory link between mutant KRAS and BCL6, we overexpressed different doxycycline-inducible G12 KRAS mutant variants (G12C, G12D, G12S, and G12V) in 293T cells, all of which commonly occur in human lung cancer.